Novocure Ltd. (NVCR) Social Stream
NOVOCURE LTD (NVCR) Price Targets From Analysts
Use the tables below to see what analysts covering NOVOCURE LTD think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-02 | 7 | $200 | $85 | $151.5 | $13.54 | 1018.91% |
| 2022-01-03 | 8 | $200 | $82 | $141.571 | $13.54 | 945.58% |
| 2022-01-06 | 8 | $200 | $82 | $134.428 | $13.54 | 892.82% |
| 2022-01-11 | 8 | $200 | $45 | $112.285 | $13.54 | 729.28% |
| 2022-01-20 | 8 | $200 | $45 | $112.285 | $13.54 | 729.28% |
| 2022-02-02 | 9 | $200 | $45 | $110.5 | $13.54 | 716.1% |
| 2022-02-08 | 9 | $200 | $45 | $120.444 | $13.54 | 789.54% |
| 2022-02-25 | 9 | $200 | $45 | $114.777 | $13.54 | 747.69% |
| 2022-05-08 | 9 | $200 | $45 | $114.333 | $13.54 | 744.41% |
| 2022-05-13 | 9 | $200 | $45 | $111.555 | $13.54 | 723.89% |
| 2022-06-06 | 10 | $200 | $45 | $111.9 | $13.54 | 726.44% |
| 2022-07-11 | 9 | $200 | $45 | $113.444 | $13.54 | 737.84% |
| 2022-07-29 | 9 | $200 | $45 | $110.111 | $13.54 | 713.23% |
| 2022-08-02 | 7 | $200 | $45 | $98.875 | $13.54 | 630.24% |
| 2022-10-24 | 7 | $200 | $45 | $96.375 | $13.54 | 611.78% |
| 2022-10-28 | 7 | $200 | $45 | $94.125 | $13.54 | 595.16% |
| 2022-11-29 | 8 | $200 | $43 | $96.25 | $13.54 | 610.86% |
| 2022-12-06 | 8 | $200 | $43 | $96.125 | $13.54 | 609.93% |
| 2022-12-22 | 8 | $200 | $43 | $96.5 | $13.54 | 612.7% |
| 2023-01-06 | 8 | $200 | $65 | $107.428 | $13.54 | 693.41% |
| 2023-01-12 | 8 | $200 | $65 | $111.142 | $13.54 | 720.84% |
| 2023-01-17 | 7 | $135 | $65 | $98 | $13.54 | 623.78% |
| 2023-02-23 | 7 | $130 | $65 | $97.166 | $13.54 | 617.62% |
| 2023-03-29 | 7 | $130 | $50 | $89 | $13.54 | 557.31% |
| 2023-05-05 | 7 | $115 | $50 | $83.166 | $13.54 | 514.22% |
| 2023-05-31 | 7 | $115 | $50 | $82.666 | $13.54 | 510.53% |
| 2023-06-07 | 6 | $104 | $46 | $78.4 | $13.54 | 479.03% |
| 2023-07-27 | 4 | $104 | $46 | $74.25 | $13.54 | 448.38% |
| 2023-07-28 | 4 | $102 | $45 | $69.5 | $13.54 | 413.29% |
| 2023-07-31 | 5 | $102 | $33 | $62.2 | $13.54 | 359.38% |
| 2023-08-04 | 6 | $102 | $33 | $60.333 | $13.54 | 345.59% |
| 2023-08-15 | 6 | $102 | $33 | $60.333 | $13.54 | 345.59% |
| 2023-08-28 | 6 | $102 | $23 | $54 | $13.54 | 298.82% |
| 2023-08-29 | 6 | $49 | $23 | $35.166 | $13.54 | 159.72% |
| 2023-10-26 | 6 | $49 | $23 | $33.833 | $13.54 | 149.87% |
| 2023-11-28 | 7 | $49 | $15 | $29.428 | $13.54 | 117.34% |
The Trend in the Analyst Price Target
NVCR's average price target has moved down $91.02 over the prior 22 months.
Over the past 46 weeks, NVCR's average upside potential has been 76.79%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-23 | 7 | 130 | 65 | 97.166 | 78.29 | 24.11% |
| 2023-06-07 | 6 | 104 | 46 | 74.500 | 48.66 | 53.1% |
| 2023-07-28 | 5 | 102 | 45 | 69.500 | 33.32 | 108.58% |
| 2023-10-26 | 6 | 49 | 21 | 31.833 | 13.02 | 144.49% |
| 2023-11-20 | 7 | 49 | 15 | 29.428 | 12.19 | 141.41% |
NVCR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.14 | 3 | 0 | 4 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 22 months, NVCR's average broker recommendation rating improved by 0.86.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, NOVOCURE LTD's upside potential (average analyst target price relative to current price) is greater than 4754.81% of them.
- To contextualize these metrics, consider that out of all US stocks, NOVOCURE LTD's variance in analysts' estimates is lower than -4449.51% of them.
- NVCR has a higher number of analysts covering the stock than 620.07% of stocks in the large market cap category.
- In terms of how NOVOCURE LTD fares relative to Healthcare stocks, note that its average analyst price target is greater than 3719.42% of that group.
In the Medical Equipment industry, PODD, DXCM, and RMD are the three stocks most similar to NOVOCURE LTD regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is NVCR a Buy, Hold or Sell? See the POWR Ratings now!